NeurologyLive® Friday 5 — November 26, 2021

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Moving Toward a More Personalized MS Treatment Journey

The field of MS is shifting focus to issues such as understanding and tracking disease progression, approaches to treatment initiation, and the roles of diet and exercise in pathogenesis and disease course. In the November special issue of NeurologyLive^®, editor-in-chief Mitzi Joi Williams, MD, offers context on that shift.

2: Karl Doghramji, MD, on the Advances in Sleep Disorder Care in 2021

The medical director of the Jefferson Sleep Disorders Center at the Vickie and Jack Farber Institute for Neuroscience of Jefferson Health offered his insight into the current state of care for sleep and the progress made this year and provided a look into some of the challenges the field is facing.

3: NeuroVoices: Orrin Devinsky, MD, on Unanswered Questions With SUDEP, Heart Rate Variability

The director of the Comprehensive Epilepsy Center at NYU Langone discussed his recently published research, which identified a novel biomarker for sudden unexpected death in epilepsy, discussed the large-scale impact heart rate variability has on preventing SUDEP, and posed the unanswered questions that remain.

4: The Therapeutic Space for People Living With Headache After COVID-19 Infection

Although headache and COVID-19 have been linked together in the literature, more studies are needed to better understand the pathophysiology of these headaches and to determine the best treatment options. Nina Riggins, MD, PhD, provided insight into the landscape of this intersection.

5: Parkinson Disease: Advice for Community Neurologists

IN episode 14 of this NeurologyLive^® Peer Exchange series, "Parkinson’s Disease On-Demand Morning Therapy," expert neurologists including Stuart Isaacson, MD; Laxman Bahroo, DO; Khashayar Dashtipour, MD; Daniel E. Kremens, MD, JD; and William Ondo, MD, provide insight on how to decide on an on-demand therapy for Parkinson’s disease and provide some general advice.

—————————————————

Introducing: Giants of Multiple Sclerosis™

Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.

Nominate Someone Today for a 2022 Giants of Multiple Sclerosis™ Award

• Nominations are open through January 31, 2022
• The Giants of Multiple Sclerosis™ Steering Committee will vet all nominations and vote to determine the 2022 inductees
• Nominees will be selected on the merits of their lifetime work.
• One honoree in each category who makes a measurable difference in the lives of patients will be awarded.
• The 2022 Giants of Multiple Sclerosis™ inaugural class will be announced in Spring of 2022

Nominate someone here.